These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 37556519)
1. The Patient-Physician Relationship and Adherence: Observations From a Clinical Study. Perche PO; Singh R; Cook MK; Kelly KA; Balogh EA; Richardson I; Feldman SR J Drugs Dermatol; 2023 Aug; 22(8):838-839. PubMed ID: 37556519 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies. Stein L; Kircik L; Fowler J; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Liu H; Jacovella J J Drugs Dermatol; 2014 Mar; 13(3):316-23. PubMed ID: 24595578 [TBL] [Abstract][Full Text] [Related]
3. Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Taieb A; Ortonne JP; Ruzicka T; Roszkiewicz J; Berth-Jones J; Peirone MH; Jacovella J; Br J Dermatol; 2015 Apr; 172(4):1103-10. PubMed ID: 25228137 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study. Gold LS; Papp K; Lynde C; Lain E; Gooderham M; Johnson S; Kerrouche N J Drugs Dermatol; 2017 Sep; 16(9):909-916. PubMed ID: 28915286 [TBL] [Abstract][Full Text] [Related]
6. Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study. Taieb A; Khemis A; Ruzicka T; Barańska-Rybak W; Berth-Jones J; Schauber J; Briantais P; Jacovella J; Passeron T; J Eur Acad Dermatol Venereol; 2016 May; 30(5):829-36. PubMed ID: 26691278 [TBL] [Abstract][Full Text] [Related]
7. A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea. Schaller M; Kemény L; Havlickova B; Jackson JM; Ambroziak M; Lynde C; Gooderham M; Remenyik E; Del Rosso J; Weglowska J; Chavda R; Kerrouche N; Dirschka T; Johnson S J Am Acad Dermatol; 2020 Feb; 82(2):336-343. PubMed ID: 31150711 [TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States. Taieb A; Stein Gold L; Feldman SR; Dansk V; Bertranou E J Manag Care Spec Pharm; 2016 Jun; 22(6):654-65. PubMed ID: 27231793 [TBL] [Abstract][Full Text] [Related]
9. Real-life experience on effectiveness and tolerability of topical ivermectin in papulopustular rosacea and antiparasitic effect on Demodex mites. Trave I; Merlo G; Cozzani E; Parodi A Dermatol Ther; 2019 Nov; 32(6):e13093. PubMed ID: 31579993 [TBL] [Abstract][Full Text] [Related]
10. Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials. Stein Gold L; Kircik L; Fowler J; Jackson JM; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Sugarman J; Liu H; Jacovella J; J Drugs Dermatol; 2014 Nov; 13(11):1380-6. PubMed ID: 25607706 [TBL] [Abstract][Full Text] [Related]
11. Quality of Life and Its Association With Treatment Satisfaction, Adherence to Medication, and Trust in Physician Among Patients With Hypertension: A Cross-Sectional Designed Study. Jneid S; Jabbour H; Hajj A; Sarkis A; Licha H; Hallit S; Khabbaz LR J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):532-542. PubMed ID: 29916266 [TBL] [Abstract][Full Text] [Related]
12. Interventions for rosacea. van Zuuren EJ; Fedorowicz Z; Carter B; van der Linden MM; Charland L Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD003262. PubMed ID: 25919144 [TBL] [Abstract][Full Text] [Related]
13. Perception of accountability decreases with age: observations from a clinical study of patients with rosacea. Cook MK; Kelly KA; Perche PO; Singh R; Richardson I; Feldman SR Arch Dermatol Res; 2023 Aug; 315(6):1809-1811. PubMed ID: 36652005 [TBL] [Abstract][Full Text] [Related]
14. Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments. Steinhoff M; Vocanson M; Voegel JJ; Hacini-Rachinel F; Schäfer G Adv Ther; 2016 Sep; 33(9):1481-501. PubMed ID: 27432381 [TBL] [Abstract][Full Text] [Related]
15. Concerns and Treatment Satisfaction in Patients Being Treated With Azelaic Acid Foam for Rosacea. Williamson T; Cameron J; McLeod K; Turner B; Quillen A; LaRose A; Lott J; Gaiser A J Drugs Dermatol; 2019 Apr; 18(4):381-386. PubMed ID: 31013011 [TBL] [Abstract][Full Text] [Related]
16. The Effects of Physicians' Communication and Empathy Ability on Physician-Patient Relationship from Physicians' and Patients' Perspectives. Wang Y; Wu Q; Wang Y; Wang P J Clin Psychol Med Settings; 2022 Dec; 29(4):849-860. PubMed ID: 35089529 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of topical ivermectin and impact on quality of life in patients with papulopustular rosacea: A systematic review and meta-analysis. Husein-ElAhmed H; Steinhoff M Dermatol Ther; 2020 Jan; 33(1):e13203. PubMed ID: 31863543 [TBL] [Abstract][Full Text] [Related]
18. Ivermectin 1% (CD5024) for the treatment of rosacea. Sahni DR; Feldman SR; Taylor SL Expert Opin Pharmacother; 2018 Apr; 19(5):511-516. PubMed ID: 29544355 [TBL] [Abstract][Full Text] [Related]
19. Clinical and erythema-directed imaging evaluation of papulo-pustular rosacea with topical ivermectin: a 32 weeks duration study. Dall'Oglio F; Lacarrubba F; Luca M; Boscaglia S; Micali G J Dermatolog Treat; 2019 Nov; 30(7):703-707. PubMed ID: 30663445 [No Abstract] [Full Text] [Related]
20. Ivermectin: A Review in Rosacea. Deeks ED Am J Clin Dermatol; 2015 Oct; 16(5):447-52. PubMed ID: 26254001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]